Literature DB >> 342253

Perspectives in cancer research. Increased selectivity of drugs by linking to carriers.

A Trouet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 342253     DOI： 10.1016/0014-2964(78)90167-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  12 in total

1.  Characterization of subcellular components in synchronized hepatoma cells as a function of the cell cycle.

Authors:  J Quintart; J Bartholeyns; P Baudhuin
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

2.  Stability of lipid vesicles in tissues of the mouse: a gamma-ray perturbed angular correlation study.

Authors:  M R Mauk; R C Gamble
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

Authors:  A Trouet; M Masquelier; R Baurain; D Deprez-De Campeneere
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data.

Authors:  A Trouet; D Deprez-De Campeneere
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

5.  Development of new derivatives of primaquine by association with lysosomotropic carriers.

Authors:  A U Trouet; P Pirson; R Steiger; M Masquelier; R Baurain; J Gillet
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

6.  Inhibition of a mouse hepatoma by the alkylating agent Trenimon linked to immunoglobulins.

Authors:  T Ghose; A Guclu; R R Raman; A H Blair
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man. Comparison with free doxorubicin.

Authors:  R Baurain; D Deprez-De Campeneere; A Zenebergh; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 8.  Potential of liposomes as drug-carriers in cancer chemotherapy: a review.

Authors:  S B Kaye; V J Richardson
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.

Authors:  D G Gilliland; Z Steplewski; R J Collier; K F Mitchell; T H Chang; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Control of in vitro cytotoxicity of positively charged liposomes.

Authors:  E A Panzner; V K Jansons
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.